Physician profile
Matthew Davis
NPI 1710253117
$9,736.38
in general payments reported to CMS, 2019-2025
9 companies · $6,687 in 2025
The $6,687 reported for 2025 was more than what 93% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2020: $1,169 · 2021: $354 · 2022: $208 · 2023: $838 · 2024: $327 · 2025: $6,687.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,662 · Travel and Lodging: $1,558 · Food and Beverage: $632.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,661.93 |
| Travel and Lodging | $1,558.48 |
| Food and Beverage | $631.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,382.22 | 2023-2025 | Da Vinci Surgical System |
| Medtronic USA, INC. | $1,064.36 | 2020 | |
| Boston Scientific Corporation | $593.37 | 2021-2023 | Lithovue, Advantage System, Lumenis Pulse 120h |
| Dendreon Pharmaceuticals LLC | $235.15 | 2023-2025 | Provenge |
| Medtronic, INC. | $161.21 | 2021 | |
| Asensus Surgical, INC. | $153.48 | 2019 | |
| Intercept Pharmaceuticals, INC. | $104.55 | 2020 | |
| Sun Pharmaceutical Industries INC. | $21.67 | 2024 | |
| Teleflex LLC | $20.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.